BIOENGINEER.ORG

In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a phase 2 clinical trial investigating...

In a groundbreaking development that could reshape the landscape of hemorrhagic fever research and vaccine development, scientists have uncovered the pivotal role of a mucin-like...

In the high-stakes arena of liver cancer surgery, the ability to predict post-operative complications is not just advantageous—it can be life-saving. A groundbreaking prospective study...

In the relentless battle against gliomas, a notoriously aggressive and often deadly form of brain cancer, the quest for effective immunotherapy targets remains a paramount...

In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence positioning E2F transcription factor 2 (E2F2) as a promising therapeutic target for...

In a groundbreaking study that could redefine the future of regenerative medicine and blood disorder treatments, researchers from the Josep Carreras Leukaemia Research Institute have...

In a groundbreaking study published in Genes and Immunity in 2025, researchers led by Xu, Guo, and Ning have delivered an unprecedented comprehensive analysis of...

In recent years, the field of oncology has witnessed a surge of interest in the intricate relationship between autophagy and oncogenic RAS-driven cancers. The latest...

In the realm of genetic disorders, Hemophilia A (HA) stands out as a complex bleeding disorder rooted in the X-linked factor VIII gene, known as...

Air pollution has been a growing concern globally, and recent research reveals that its interplay with urban development and green spaces can significantly impact asthma...

In a groundbreaking advancement in the intersection of immunogenetics and infectious disease, a team of researchers has unveiled compelling evidence linking human leukocyte antigen (HLA)...

In a groundbreaking advancement in the fight against Human Immunodeficiency Virus (HIV), researchers have reported promising results from a novel therapeutic approach using autologous HIV-specific...

In the relentless quest to overhaul cancer treatment paradigms, tumor-infiltrating lymphocytes (TILs) immunotherapy emerges as a beacon of hope, particularly for Non-small Cell Lung Cancer...

In a groundbreaking study poised to shift the paradigm of glioblastoma treatment, researchers have unveiled compelling evidence that gabapentinoids, a class of drugs traditionally employed...

In a groundbreaking advance that could reshape immunotherapeutic strategies, a recent study published in Genes & Immunity sheds new light on the nuanced effects of...